SBIR/STTR Research Award
Biodegradable Scaffolds Optimized for Cartilage Repair
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- OSTEOBIOLOGICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (Provided by Applicant): This project proposes the development of a
biologically "friendly" scaffold for articular cartilage repair. Utilizing a
fiber-reinforced, mechanically appropriate scaffold, the surface of the
polymeric device will be coated with various cell attachment factors to improve
the adherence and proliferation of cells/tissue. No synthetic scaffolds are
currently approved in the U.S. for articular cartilage repair. Our long-range
goal is to commercially produce an implant which, when combined with cells, can
successfully heal cartilage defects. In this proposal, the objective is to
evaluate the in vitro growth of articular chondrocytes on scaffolds coated with
numerous treatments. The ability of the cell-laden, surface-treated scaffolds
to form cartilage will also be confirmed subcutaneously in mice. This
innovative project will enhance the biological properties of a synthetic
scaffold so that minimal manipulation of added cells is required. Specific
clinical indications include full thickness cartilage defects in weight-bearing
regions of articulating joints, most frequently the knee. In Phase I we will
identify at least one surface treatment/cell loading combination which shows
superior cell/tissue growth in vitro and in vivo. Phase II will test the
constructs in animals and prepare for clinical studies by testing potential
sources for human cells. Regulatory approval and marketing plans will be
finalized in Phase III.
PROPOSED COMMERCIAL APPLICATIONS:
From 1990-1996 total knee replacements procedures soared almost 90 percent. A reliable, cost-effective treatment for cartilage defects can stabilize further degeneration thus avoiding a total joint replacement. The proposed device will be placed in osteochondral/chondral defects to promote cartilage ingrowth in order to reestablish the articular joint surface. Benefits of such a device include off-the shelf availability, enhanced biological properties to reduce cell manipulation, and an environment conducive for tissue repair.
Technology keywords
Not reported